Clinical Trials Logo

Citation(s)

A Phase I Study to Examine the Safety and Efficacy of Allogeneic MSCs in Promoting T-regulatory Cell Immune Suppressor Function in Patients With Small Abdominal Aortic Aneurysms (AAA)

Details for clinical trial NCT02843854